Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Ingredion Inc. (INGR) Stock Forecast & Price Prediction United States | NYSE | Consumer Defensive | Packaged Foods
$135.71
-0.64 (-0.47%)Did INGR Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Ingredion is one of their latest high-conviction picks.
Based on our analysis of 9 Wall Street analysts, INGR has a neutral consensus with a median price target of $149.00 (ranging from $135.34 to $168.00). Currently trading at $135.71, the median forecast implies a 9.8% upside. This outlook is supported by 2 Buy, 5 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Benjamin Theurer at Barclays, projecting a 23.8% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for INGR.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Jul 9, 2025 | UBS | Cody Ross | Neutral | Maintains | $151.00 |
Apr 22, 2025 | Oppenheimer | Kristen Owen | Outperform | Maintains | $155.00 |
Apr 7, 2025 | UBS | Cody Ross | Neutral | Downgrade | $145.00 |
Feb 5, 2025 | Stephens & Co. | Ben Bienvenu | Equal-Weight | Maintains | $150.00 |
Feb 5, 2025 | BMO Capital | Andrew Strelzik | Market Perform | Maintains | $133.00 |
Feb 5, 2025 | Oppenheimer | Kristen Owen | Outperform | Maintains | $167.00 |
Nov 15, 2024 | UBS | Cody Ross | Buy | Maintains | $173.00 |
Nov 6, 2024 | Oppenheimer | Kristen Owen | Outperform | Maintains | $178.00 |
Nov 6, 2024 | Barclays | Benjamin Theurer | Overweight | Maintains | $168.00 |
Nov 6, 2024 | BMO Capital | Andrew Strelzik | Market Perform | Maintains | $147.00 |
Oct 21, 2024 | Oppenheimer | Kristen Owen | Outperform | Maintains | $147.00 |
Aug 15, 2024 | UBS | Cody Ross | Buy | Maintains | $148.00 |
Aug 9, 2024 | Barclays | Benjamin Theurer | Overweight | Upgrade | $145.00 |
Aug 7, 2024 | BMO Capital | Andrew Strelzik | Market Perform | Maintains | $128.00 |
Aug 7, 2024 | Oppenheimer | Kristen Owen | Outperform | Maintains | $138.00 |
May 9, 2024 | BMO Capital | Andrew Strelzik | Market Perform | Maintains | $120.00 |
Mar 6, 2024 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $122.00 |
Feb 16, 2024 | Goldman Sachs | Adam Samuelson | Buy | Maintains | $135.00 |
Feb 15, 2024 | Goldman Sachs | Adam Samuelson | Buy | Upgrade | $135.00 |
Feb 7, 2024 | Stephens & Co. | Ben Bienvenu | Overweight | Reiterates | $130.00 |
The following stocks are similar to Ingredion based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Ingredion Inc. has a market capitalization of $8.73B with a P/E ratio of 14.3x. The company generates $7.36B in trailing twelve-month revenue with a 8.5% profit margin.
Revenue growth is -3.7% quarter-over-quarter, while maintaining an operating margin of +15.6% and return on equity of +16.3%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Produces starches and sweeteners from various raw materials.
Ingredion operates by supplying a wide range of ingredients that improve the quality and functionality of food and beverages. It generates revenue through the sale of its diverse product portfolio, which includes sweeteners, starches, and specialty ingredients, catering to both industrial clients and consumer markets.
The company is positioned within the diversified industrial and consumer staples sector, addressing key market trends such as clean label and non-GMO products. With a strong global presence, Ingredion impacts multiple industries, including food and beverage, pharmaceuticals, and packaging, by offering healthier and more sustainable ingredient alternatives.
Consumer Defensive
Packaged Foods
11,000
Mr. James P. Zallie
United States
1997
BYND, HRL and TSN are transforming food with AgTech, from lab-grown meat to smart farming and plant-based proteins.
INGR vs. CELH: Which Stock Is the Better Value Option?
Ingredion Incorporated (NYSE: INGR) will release its Q2 2025 financial results on August 1, 2025, before market opening.
Ingredion's upcoming earnings report will reveal its financial health and performance trends, influencing investor sentiment and potential stock movement in the food ingredient sector.
Zacks emphasizes its Rank system based on earnings estimates and revisions, while also monitoring value, growth, and momentum trends to identify strong stock picks.
Zacks' focus on earnings estimates and revisions signals potential stock performance, guiding investors toward top picks based on value, growth, and momentum trends.
Investors are evaluating value opportunities between Ingredion (INGR) and Celsius Holdings Inc. (CELH) in the Food - Miscellaneous sector.
The comparison between Ingredion and Celsius Holdings highlights potential investment opportunities, influencing stock selection and portfolio strategies in the Food sector.
As consumer confidence declines, low-beta stocks like MO, INGR, and ATO are highlighted for their growth potential and stable yields.
Dipping consumer confidence may prompt investors to seek stability in low-beta stocks like MO, INGR, and ATO, which provide growth potential and reliable dividends amid market volatility.
The Federal Reserve has maintained steady interest rates, prompting investors to favor low-beta consumer staples like PM and KO as safer investment options amid global tensions.
Stable interest rates amid global tensions boost low-beta consumer staples like PM and KO, indicating a shift towards safer investments during uncertain times.
Univar Solutions is expanding into Belgium, the Netherlands, and Luxembourg to cater to increasing consumer demand for healthier, sustainable, and flavorful products.
Univar Solutions' expansion into Belgium, Netherlands, and Luxembourg signals growth potential in health-conscious markets, likely boosting revenue and market share, which can positively impact stock performance.
Based on our analysis of 9 Wall Street analysts, Ingredion Inc. (INGR) has a median price target of $149.00. The highest price target is $168.00 and the lowest is $135.34.
According to current analyst ratings, INGR has 2 Buy ratings, 5 Hold ratings, and 0 Sell ratings. The stock is currently trading at $135.71. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict INGR stock could reach $149.00 in the next 12 months. This represents a 9.8% increase from the current price of $135.71. Please note that this is a projection by Wall Street analysts and not a guarantee.
Ingredion operates by supplying a wide range of ingredients that improve the quality and functionality of food and beverages. It generates revenue through the sale of its diverse product portfolio, which includes sweeteners, starches, and specialty ingredients, catering to both industrial clients and consumer markets.
The highest price target for INGR is $168.00 from Benjamin Theurer at Barclays, which represents a 23.8% increase from the current price of $135.71.
The lowest price target for INGR is $135.34 from at , which represents a -0.3% decrease from the current price of $135.71.
The overall analyst consensus for INGR is neutral. Out of 9 Wall Street analysts, 2 rate it as Buy, 5 as Hold, and 0 as Sell, with a median price target of $149.00.
Stock price projections, including those for Ingredion Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.